Society for Cardiovascular Magnetic Resonance perspective on the ACC/AHA/ASE/ASNC/ASPC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2023 multi-modality appropriate use criteria for the detection and risk assessment of chronic coronary disease

W Patricia Bandettini; Raymond Y Kwong; Amit R Patel; Sven Plein; Society for Cardiovascular Magnetic Resonance

doi:10.1186/s12968-023-00959-4

Society for Cardiovascular Magnetic Resonance perspective on the ACC/AHA/ASE/ASNC/ASPC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2023 multi-modality appropriate use criteria for the detection and risk assessment of chronic coronary disease

J Cardiovasc Magn Reson. 2023 Oct 19;25(1):59. doi: 10.1186/s12968-023-00959-4.

Authors

W Patricia Bandettini¹, Raymond Y Kwong², Amit R Patel³, Sven Plein⁴; Society for Cardiovascular Magnetic Resonance

Affiliations

¹ National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
² Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
³ Cardiovascular Division, Department of Medicine, University of Virginia, Charlottesville, VA, USA.
⁴ Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK. S.Plein@leeds.ac.uk.

No abstract available

Keywords: Appropriate use; Cardiovascular magnetic resonance imaging; Chest pain; Chronic coronary disease; Guideline; Ischemia; Risk assessment; Society for Cardiovascular Magnetic Resonance.

Publication types

Review

MeSH terms

Coronary Disease*
Heart Diseases*
Humans
Magnetic Resonance Spectroscopy
Predictive Value of Tests
Risk Assessment
United States